Can a simple blood test help predict breast Cancer's next move?
NCT ID NCT07584213
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at nearly 3,000 women with early-stage invasive breast cancer to see if routine blood test results, along with tumor details, can help predict how the disease will progress. Researchers will track cancer recurrence and survival over time. The goal is to find simple, widely available markers that could guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER INVASIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Shanghai, 200127, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New combo approach for breast cancer: reconstruction and radiation together
- Fingernail moons may reveal who responds to breast cancer therapy
- Small study aims to predict which breast cancer patients benefit from immunotherapy
- Blood test could revolutionize breast cancer monitoring
- New 3D ultrasound aims to improve breast cancer diagnosis without radiation
- Music therapy may soothe anxiety in breast cancer patients